Effect of inhaled fluticasone propionate on laryngotracheal stenosis after balloon dilation: a randomized controlled trial

Eur Arch Otorhinolaryngol. 2021 May;278(5):1505-1513. doi: 10.1007/s00405-021-06622-x. Epub 2021 Jan 26.

Abstract

Purpose: Laryngotracheal stenosis describes various airflow compromising conditions leading to laryngeal and tracheal narrowing, including subglottic and tracheal stenosis. Direct laryngobronchoscopy is the diagnostic gold standard for laryngotracheal stenosis. This study aimed to explore the effect of inhaled fluticasone propionate as adjuvant medical therapy in patients with laryngotracheal stenosis after balloon dilation.

Methods: This prospective randomized controlled trial was conducted from April 2019 to April 2020. Fourteen adults (≥ 18 years) with laryngotracheal stenosis consented to participate. All patients underwent endoscopic balloon dilation. Seven patients were treated with inhaled fluticasone propionate, and seven acted as controls. Detailed documentation of operative findings and pre- and post-balloon dilation spirometry measurements were recorded. Basic demographic data and operative details, including information about the percentage of laryngotracheal stenosis, distance of laryngotracheal stenosis from the vocal cords, the stenotic segment vertical length, and the largest endotracheal tube used before and after dilation were noted.

Results: Spirometry measurements were obtained on 34 occasions (17 before and 17 after balloon dilation). The two groups were similar in spirometry values after treatment. Both groups had significantly improved on most spirometry values after balloon dilation.

Conclusion: We found that using inhaled steroids after balloon dilatation in patients with laryngotracheal stenosis had no benefit over non-user patients in spirometry parameters during the short postoperative follow-up. To confirm this outcome, we recommend a large-scale double-blind study with a longer follow-up period.

Keywords: Adjuvant medical therapy; Balloon dilation; Fluticasone propionate inhaler; Inhaled corticosteroid; Laryngotracheal stenosis; Pulmonary function test; Subglottic stenosis; Wound healing modifying agent.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Constriction, Pathologic
  • Dilatation
  • Fluticasone
  • Humans
  • Laryngostenosis* / etiology
  • Laryngostenosis* / therapy
  • Prospective Studies
  • Tracheal Stenosis* / etiology
  • Tracheal Stenosis* / therapy
  • Treatment Outcome

Substances

  • Fluticasone